DSIP
SleepOverview
Delta sleep-inducing peptide studied for sleep regulation, stress resilience and neuroendocrine research.
Mechanism of Action
DSIP, or delta sleep-inducing peptide, has been studied as a neuromodulatory peptide with possible effects on sleep-related and stress-responsive pathways. Its exact mechanism remains incompletely defined, but researchers have proposed interactions with neuroendocrine signaling, hypothalamic-pituitary regulation, and broader arousal systems rather than a single well-established receptor pathway.
Reported Research Observations
In preclinical and limited human research contexts, DSIP has been associated with changes in sleep architecture, stress resilience, and neuroendocrine markers, although findings are not uniform across studies. Researchers have also observed interest in its potential relevance to autonomic balance and adaptation to stress, but the overall evidence base remains exploratory and mixed.
Quick Facts
- Commonly Available Vial Sizes
- 2 mg, 5 mg, 10 mg, 15 mg
- Typical Research Dose
- 100 – 300 mcg
- Suggested BAC Water
- 2 mL
- Category
- Sleep
Safety & Handling
DSIP is intended for research-use-only and should be handled according to standard laboratory practices, with attention to peptide purity, contamination control, and appropriate documentation. When reconstituted for laboratory work, bacteriostatic water is commonly used in research settings, and the material is typically protected from excess heat and light and stored refrigerated according to protocol; specific handling should follow the supplier's instructions and institutional guidelines.
Notes
Available in 2mg, 5mg, 10mg vials | Dosing: Once daily before bed, or every 2-3 days, 10-30 days. Route: Subcutaneous (SC)
Commonly Researched Together
Further Reading
For laboratory and research use only. Not for human consumption or clinical use. Information is provided for reference and does not constitute medical advice.